Cerebrolysin® reduces microglial activation in vivo and in vitro: A potential mechanism of neuroprotection

Journal of Neural Transmission, Supplement

Volumn , Issue 59, 2000, Pages 281-292

  Álvarez, X Anton ^a   Lombardi, V R M ^a   Fernandez Novoa L ^a   Garcia M ^a   Sampedro, C ^a   Cagiao, A ^a   Cacabelos, R ^a   Windisch, M ^b  

^a Centro de Investigacion Biomedica EuroEspes   (Spain)

^b JSW Life Sciences GmbH   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED GROWTH FACTOR; CEREBROLYSIN; NERVE GROWTH FACTOR; NEUROTROPHIN; NEUROTROPHIN 3; NOOTROPIC AGENT; AMINO ACID; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; INTERLEUKIN 1; LIPOPOLYSACCHARIDE; NEUROPROTECTIVE AGENT; PEPTIDE FRAGMENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CELL DEATH; CELL FUNCTION; CONTROLLED STUDY; DEGENERATIVE DISEASE; FEMALE; INFLAMMATION; MICROGLIA; NERVE CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; BRAIN CORTEX; CELL CULTURE; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; HIPPOCAMPUS; METABOLISM; NERVE DEGENERATION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

AMINO ACIDS; AMYLOID BETA-PROTEIN; ANIMALS; CELLS, CULTURED; CEREBRAL CORTEX; FEMALE; HIPPOCAMPUS; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; MICROGLIA; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; NOOTROPIC AGENTS; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0033624436     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6781-6_30     Document Type: Article

References (26)

1. Álvarez XA, Franco A, Fernández-Novoa L, Cacabelos R (1996) Blood levels of histamine, IL-1β and TNF-α in patients with mild to moderate Alzheimer's disease. Mol Chem Neuropathol 29: 237-252
2. Cacabelos R, Barquero M, García P, Álvarez XA, Varela de Scijas E (1991) Cerebrospinal fluid interleukin-1β (IL-β) in Alzheimer's disease and neurological disorders. Meth Find Exp Clin Pharmacol 13: 455-458
3. Cacabelos R, Álvarez XA, Fernández-Novoa L, Franco-Maside A, Mangues R, Pellicer A, Nishimura T (1994) Brain interleukin-1β in Alzheimer's disease and vascular dementia. Meth Find Exp Clin Pharmacol 16: 141-151
4. Davis ES, Foster TD, Thomas WE (1994) Cellular forms and functions of brain microglia. Brain Res Bull 34: 73-78
5. Dickson DW, Mattiace LA, Kure K, Hutchins K, Lyman WD, Brosnan CF (1991) Biology of disease. Microglia in human disease, with an emphasis on acquired immune deficiency syndrome. Lab Invest 64: 135-155
6. Dickson DW, Lee SS, Mattiace LA, Yen SC, Brosnan C (1993) Microglia and cytokines in neurological disease, with special references to AIDS and Alzheimer's disease. Glia 7: 75-83
7. Fagarasan MO, Aisen PS (1996) IL-1 and anti-inflammatory drugs modulate A beta cytotoxicity in PC12 cells. Brain Res 723: 231-234
8. Hauss Wegrzyniak B, Dobrzanski P, Stoehr JD, Wenk GL (1998) Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease. Brain Res 780: 294-303
9. Lawson LJ, Perry VH, Dri P, Gordon S (1990) Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 39: 151-170
10. Lee GJ (1993) The possible contribution of microglia and macrophages to delayed neuronal death after ischemia. J Neurol Sci 114: 119-122
11. Lombardi VRM, García M, Cacabelos R (1998a) Microglial activation induced by factor(s) contained in sera from Alzheimer-related ApoE genotypes. J Neurosci Res 54: 539-553
12. Lombardi VRM, Maneiro E, Cacabelos R (1998b) Apoptosis in neurodegenerative diseases: The neuroimmune network. Neurogeront Neurogeriat 2: 105-124
13. Lorton D, Kocsis JM, King L, Madden K, Brunden KR (1996) beta-Amyloid induces increased release of interleukin-1 beta from lipopolysaccharide-activated human monocytes. J Neuroimmunol 67: 21-29
14. Maneiro E, Lombardi VRM, Cacabelos R (1996) Rat cell cultures: experimental model to study neurodegenerative disorders and new pharmacological compounds. Meth Find Exp Clin Pharmacol 18: 615-645
15. Maneiro E, Lombardi VRM, Cacabelos R (1998) Neuroimmune dysfunction in Alzheimer's disease. Neurogeront Neurogeriat 2: 77-104
16. McGeer PL, Itagaki S, Boyes BE, McGeer EG (1988) Reactive microglia are positive for HLA-DR in the substancia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38: 1285-1291
17. Meda L, Cassatella MA, Szendrei GI, Otvos L, Baron P, Villalba M, Ferrari D, Rossi F (1995) Activation of microglia cells by beta amyloid protein and interferon-gamma. Nature 374: 647-650
18. Miguel-Hidalgo JJ, Cacabelos R (1998) β-Amyloid(1-40)-induced neurodegeneration in the rat hippocampal neurons of the CA1 subfield. Acta Neuropathol 95: 455-465
19. Nguyen KT, Deak T, Owens SM, Kohno T, Fleshner M, Watkins LR, Maier SF (1998) Exposure to acute stress induces brain interleukin-1beta protein in the rat. J Neurosci 18: 2239-2246
20. Panegyres PK, Hughes J (1998) The neuroprotective effects of the recombinant interleukin-1 receptor antagonist rhIL-1ra after excitotoxic stimulation with kainic acid and its relationship to the amyloid precursor protein gene. J Neurol Sci 154: 123-132
21. Rosenwasser LJ (1998) Biologic activities of IL-1 and its role in human disease. J All Clin Immunol 102: 344-350
22. Sigurdsson EM, Lee JM, Dong XW, Hejna MJ, Lorens SA (1997) Bilateral injections of amyloid-beta 25-35 into the amygdala of young Fischer rats: behavioral, neurochemical, and time dependent histopathological effects. Neurobiol Aging 18: 591-608
23. Takao T, Nagano I, Tojo C, Takemura T, Makino S, Hashimoto K, De Souza EB (1996) Age-related reciprocal modulation of interleukin-1beta and interleukin-1 receptors in the mouse brain-endocrine-immune axis. Neuroimmunomodulation 3: 205-122
24. van Dam AM, Poole S, Schultzberg M, Zavala F, Tilders FJ (1998) Effects of peripheral administration of LPS on the expression of immunoreactive interleukin-1 alpha, beta, and receptor antagonist in rat brain. Ann N Y Acad Sci 840: 128-138
25. Willard LB, HaussWegrzyniak B, Wenk GL (1998) Pathological and biochemical consequences of acute and chronic neuroinflammation within the basal forebrain cholinergic system of rats. Neuroscience 88: 193-200
26. Windisch M, Gschanes A, Hutter-Paier B (1998) Neurotrophic activities and therapeutic experience with a brain derived peptide preparation. J Neural Transm [Suppl 53]: 289-298